Yahya El Mir: Ziwig Biotech Achieves U.S. Certification for Endometriosis Saliva Test – The Business Journal
The Business Journal shared a post on LinkedIn:
” [HEALTH] Ziwig Biotech Achieves U.S. Certification for Endometriosis Saliva Test.
One year after its deployment in France, the Lyon-based biotech (100 employees) will launch its test in the United States.
The product: ‘Ziwig Endotest‘, the first saliva test for the early diagnosis of endometriosis, which affects between 10 and 15% of women of childbearing age worldwide.
A flawless run in France:
- Reimbursed by the Health Insurance (~800€/test)
- 100 partner expert centres
- 22,500 patients benefiting in 2026
The test was awarded the Prix Galien International 2024 in the ‘Best Medical Technology’ category.
Partnership imminent: ‘We are conducting negotiations with several major laboratories. An agreement should be signed in the coming weeks,’ says Yahya EL MIR, founder.
Next stop: Germany.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 16, 2026, 15:25Kate Staatsen: Excited to Share My New Publication on Chronic Histiocytic Intervillositis in AJOG
-
Feb 16, 2026, 14:53ESHRE Opens Stakeholder Review for Updated IVF Laboratory Recommendations
-
Feb 16, 2026, 05:43Euploid Embryo Transfer and the Evolving Definition of Repeated Implantation Failure – Practical Gynecology and Obstetrics
-
Feb 16, 2026, 01:59Virginie Bonnefon: International Specialists to Review Advances in Reproductive Surgery
-
Feb 15, 2026, 17:11Evaluating Mid-Luteal Progesterone in Embryo Transfer Cycles – RBMO
-
Feb 15, 2026, 17:10Anis Feki: Mapping Swiss Caesarean Section Rates by Robson Classification
-
Feb 15, 2026, 14:13Enhancing Patient Counseling with 1PN Embryo Findings – RBMO
-
Feb 15, 2026, 14:08Yannick Hurni: Navigating Confounding in Target Trial Emulation Studies
-
Feb 15, 2026, 14:04Magdalena Depa-Martynow: The Role of Psychological Safety in IVF Labs